Skip to main content

Advertisement

Log in

Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study

Healthcare-associated Gram-negative BSI

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

We performed a population-based study to examine the influence of healthcare-associated acquisition on pathogen distribution, antimicrobial resistance, short- and long-term mortality of community-onset Gram-negative bloodstream infections (BSI). We identified 733 unique patients with community-onset Gram-negative BSI (306 healthcare-associated and 427 community-acquired) among Olmsted County, Minnesota, residents from 1 January 1998 to 31 December 2007. Multivariate logistic regression was used to examine the association between healthcare-associated acquisition and microbiological etiology and antimicrobial resistance. Multivariate Cox proportional hazards regression was used to evaluate the influence of the site of acquisition on mortality. Healthcare-associated acquisition was predictive of Pseudomonas aeruginosa (odds ratio [OR] 3.14, 95% confidence intervals [CI]: 1.59–6.57) and the group of Enterobacter, Citrobacter, and Serratia species (OR 2.23, 95% CI: 1.21–4.21) as causative pathogens of community-onset Gram-negative BSI. Healthcare-associated acquisition was also predictive of fluoroquinolone resistance among community-onset Gram-negative bloodstream isolates (OR 2.27, 95% CI: 1.18–4.53). Healthcare-associated acquisition of BSI was independently associated with higher 28-day (hazard ratio [HR] 3.73, 95% CI: 2.13–6.93) and 1-year mortality (HR 3.60, 95% CI: 2.57–5.15). Because of differences in pathogen distribution, antimicrobial resistance, and outcomes between healthcare-associated and community-acquired Gram-negative BSI, identification of patients with healthcare-associated acquisition of BSI is essential to optimize empiric antimicrobial therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140

    Article  PubMed  CAS  Google Scholar 

  2. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP et al (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791–797

    PubMed  Google Scholar 

  3. Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH (2006) Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med 34:2588–2595

    Article  PubMed  Google Scholar 

  4. Marschall J, Fraser VJ, Doherty J, Warren DK (2009) Between community and hospital: healthcare-associated Gram-negative bacteremia among hospitalized patients. Infect Control Hosp Epidemiol 30:1050–1056

    Article  PubMed  Google Scholar 

  5. Olesen B, Kolmos HJ, Orskov F, Orskov I (1995) A comparative study of nosocomial and community-acquired strains of Escherichia coli causing bacteraemia in a Danish University Hospital. J Hosp Infect 31:295–304

    Article  PubMed  CAS  Google Scholar 

  6. Kang CI, Kim SH, Bang JW, Kim HB, Kim NJ, Kim EC et al (2006) Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci 21:816–822

    Article  PubMed  CAS  Google Scholar 

  7. US Census Bureau. Olmsted County QuickFacts, http://quickfacts.census.gov. Accessed 21 April 2008

  8. Melton LJ 3rd (1996) History of the Rochester Epidemiology Project. Mayo Clin Proc 71:266–274

    Article  PubMed  Google Scholar 

  9. Steckelberg JM, Melton LJ 3rd, Ilstrup DM, Rouse MS, Wilson WR (1990) Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med 88:582–588

    Article  PubMed  CAS  Google Scholar 

  10. Tleyjeh IM, Steckelberg JM, Murad HS, Anavekar NS, Ghomrawi HM, Mirzoyev Z et al (2005) Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 293:3022–3028

    Article  PubMed  CAS  Google Scholar 

  11. Al-Hasan MN, Wilson JW, Lahr BD, Eckel-Passow JE, Baddour LM (2008) Incidence of Pseudomonas aeruginosa bacteremia: a population-based study. Am J Med 121:702–708

    Article  PubMed  Google Scholar 

  12. Pfaller MA, Jones RN, Marshall SA, Coffman SL, Hollis RJ, Edmond MB et al (1997) Inducible AmpC beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn Microbiol Infect Dis 28:211–219

    Article  PubMed  CAS  Google Scholar 

  13. Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR 3rd, St Sauver JL, Wilson WR et al (2007) Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med 167:834–839

    Article  PubMed  Google Scholar 

  14. Al-Hasan MN, Eckel-Passow JE, Baddour LM (2010) Recurrent gram-negative bloodstream infection: a 10-year population-based cohort study. J Infect 61:28–33

    Article  PubMed  Google Scholar 

  15. Al-Hasan MN, Eckel-Passow JE, Baddour LM (2011) Influence of referral bias on the clinical characteristics of patients with Gram-negative bloodstream infection. Epidemiol Infect. doi:10.1017/s09502688100001x

    Google Scholar 

  16. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC et al (2005) Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49:760–766

    Article  PubMed  CAS  Google Scholar 

  17. Schechner V, Nobre V, Kaye KS, Leshno M, Giladi M, Rohner P et al (2009) Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? Clin Infect Dis 48:580–586

    Article  PubMed  Google Scholar 

  18. Cheong HS, Kang CI, Wi YM, Kim ES, Lee JS, Ko KS et al (2008) Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia. Am J Med 121:709–714

    Article  PubMed  Google Scholar 

  19. Jacoby GA (2009) AmpC beta-lactamases. Clin Microbiol Rev 22:161–182

    Article  PubMed  CAS  Google Scholar 

  20. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP et al (1991) Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115:585–590

    PubMed  CAS  Google Scholar 

  21. Kaye KS, Cosgrove S, Harris A, Eliopoulos GM, Carmeli Y (2001) Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. Antimicrob Agents Chemother 45:2628–2630

    Article  PubMed  CAS  Google Scholar 

  22. Yang K, Guglielmo BJ (2007) Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms. Ann Pharmacother 41:1427–1435

    Article  PubMed  CAS  Google Scholar 

  23. Rodriguez-Bano J, de Cueto M, Retamar P, Galvez-Acebal J (2010) Current management of bloodstream infections. Expert Rev Anti Infect Ther 8:815–829

    Article  PubMed  Google Scholar 

  24. Sun HY, Chen SY, Chang SC, Pan SC, Su CP, Chen YC (2006) Community-onset Escherichia coli and Klebsiella pneumoniae bacteremia: influence of health care exposure on antimicrobial susceptibility. Diagn Microbiol Infect Dis 55:135–141

    Article  PubMed  CAS  Google Scholar 

  25. Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, Golan Y, Noy A, Schwartz D et al (2002) Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis 34:1431–1439

    Article  PubMed  Google Scholar 

  26. Kollef MH, Zilberberg MD, Shorr AF et al (2011) Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect 62:130–135

    Article  PubMed  Google Scholar 

  27. Arias E (2010) United States life tables, 2006. Natl Vital Stat Rep 58:1–40

    Google Scholar 

Download references

Acknowledgements

The authors thank Emily Vetter and Mary Ann Butler for providing us with vital data from the microbiology laboratory databases at the Mayo Clinic, Rochester and the Olmsted Medical Center. The authors thank Susan Schrage, Susan Stotz, R.N., and all the staff at the Rochester Epidemiology Project for their administrative help and support.

Funding

The study received funding from the Small Grants Program and the Baddour Family Fund at the Mayo Clinic, Rochester, MN, USA. The funding source had no role in study design.

This work was made possible by research grant R01-AG034676 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health, US Public Health Service).

Potential conflicts of interest

MNA, JEE, and LMB: No conflict.

MNA has full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. N. Al-Hasan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Hasan, M.N., Eckel-Passow, J.E. & Baddour, L.M. Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study. Eur J Clin Microbiol Infect Dis 31, 1163–1171 (2012). https://doi.org/10.1007/s10096-011-1424-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-011-1424-6

Keywords

Navigation